Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Upgrades Kroger to Overweight, Raises Price Target to $54

JP Morgan analyst Ken Goldman upgrades Kroger (NYSE:KR) from Neutral to Overweight and raises the price target from $50 to $54.
byBenzinga Newsdesk
March 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JP Morgan analyst Ken Goldman upgrades Kroger (NYSE:KR) from Neutral to Overweight and raises the price target from $50 to $54.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AffaMed Therapeutics Announced Top-Line Results From Real-World Study In China Evaluating The Safety And Efficacy Of DEXTENZA In Patients After Cataract Surgery; NOTE: AffaMed Therapeutics Has A Licensing Agreement With Ocular Therapeutix, Inc.

By Benzinga Newsdesk
October 31, 9:07 AM
AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in

OCUL